Literature DB >> 17048048

Leukocyte removal therapy for ulcerative colitis does not affect postoperative complications.

Hiroki Ikeuchi1, Takehira Yamamura, Masato Kusunoki, Hiroki Nakano, Motoi Uchino, Mitsuhiro Nakamura, Masafumi Noda, Hidenori Yanagi, Takayuki Matsumoto.   

Abstract

BACKGROUND: We investigated the incidence of postoperative complications in patients treated with or without preoperative leukocyte removal therapy (LRT).
METHODS: The case notes of 387 patients with ulcerative colitis (UC) who underwent surgical intervention were retrospectively reviewed. One hundred nine patients were treated with LRT within 8 weeks before surgery (LRT group), and 278 had not received LRT since at least 8 weeks before surgery (without LRT group). We reviewed the postoperative complications according to type of initial operation.
RESULTS: Of the patients who underwent an ileal J-pouch anal anastomosis (IPAA) without an ileostomy, 3 (6.5%) in the LRT group developed pouch-related complications (PRC), while 11 (7.5%) in the without LRT group developed PRC. The overall postoperative complication rates were 28.3% in the LRT group and 21.8% in the without LRT group. For patients who underwent an IPAA with an ileostomy, the overall rates of postoperative complications were 39.1% in the LRT group and 31.8% in the without LRT group. Among those undergoing a total colectomy, 33.3% in the LRT group and 18.2% in the without LRT group had postoperative complications. No statistically significant differences were demonstrated between the two groups with respect to postoperative complications.
CONCLUSIONS: Our results suggest that preoperative LRT does not influence the rate of postoperative complications in UC patients.

Entities:  

Mesh:

Year:  2006        PMID: 17048048     DOI: 10.1007/s00535-006-1875-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  21 in total

1.  Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.

Authors:  T Yajima; H Takaishi; T Kanai; Y Iwao; M Watanabe; H Ishii; T Hibi
Journal:  Ther Apher       Date:  1998-05

2.  Surgery in patients on long-term steroid therapy: a tentative model for risk assessment.

Authors:  R Reding; L A Michel; J Donckier; L de Canniere; J Jamart
Journal:  Br J Surg       Date:  1990-10       Impact factor: 6.939

3.  Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon.

Authors:  Koji Sawada; Akimitsu Egashira; Kunio Ohnishi; Ken Fukunaga; Takeshi Kusaka; Takashi Shimoyama
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

4.  Severe steroid-unresponsive ulcerative colitis: outcomes of restorative proctocolectomy in patients undergoing cyclosporin treatment.

Authors:  M Pinna-Pintor; P Arese; R Bona; E Falletto; R Schieroni; E Villata; N Massaioli; P Selvaggi; G C Actis; M Lagget; A Marzano; A Ottobrelli; R Sostegni; M R Torrani-Cerenzia; M Rizzetto
Journal:  Dis Colon Rectum       Date:  2000-05       Impact factor: 4.585

5.  Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.

Authors:  T Shimoyama; K Sawada; N Hiwatashi; T Sawada; K Matsueda; A Munakata; H Asakura; T Tanaka; R Kasukawa; K Kimura; Y Suzuki; Y Nagamachi; T Muto; H Nagawa; B Iizuka ; S Baba; M Nasu; T Kataoka; N Kashiwagi; A R Saniabadi
Journal:  J Clin Apher       Date:  2001       Impact factor: 2.821

6.  Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications.

Authors:  G M Hyde; D P Jewell; M G Kettlewell; N J Mortensen
Journal:  Dis Colon Rectum       Date:  2001-10       Impact factor: 4.585

7.  Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.

Authors:  Koji Sawada; Kazuo Kusugami; Yasuo Suzuki; Tadao Bamba; Akihiro Munakata; Toshifumi Hibi; Takashi Shimoyama
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

8.  A double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis.

Authors:  D Wallace; D Goldfinger; C Lowe; S Nichols; J Weiner; M Brachman; J R Klinenberg
Journal:  N Engl J Med       Date:  1982-06-10       Impact factor: 91.245

9.  Clinical results after restorative proctocolectomy without diverting ileostomy for ulcerative colitis.

Authors:  Hiroki Ikeuchi; Yasutsugu Shoji; Masato Kusunoki; Hidenori Yanagi; Masafumi Noda; Takehira Yamamura
Journal:  Int J Colorectal Dis       Date:  2003-10-14       Impact factor: 2.571

10.  Safety of azathioprine in pregnancy in inflammatory bowel disease.

Authors:  E M Alstead; J K Ritchie; J E Lennard-Jones; M J Farthing; M L Clark
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

View more
  3 in total

1.  Leukocyte removal therapy before surgery in ulcerative colitis.

Authors:  Toshiyuki Matsui
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

2.  Risk factors for surgical site infection in Japanese patients with ulcerative colitis: a multicenter prospective study.

Authors:  Toshimitsu Araki; Yoshiki Okita; Motoi Uchino; Hiroki Ikeuchi; Iwao Sasaki; Yuji Funayama; Kouhei Fukushima; Kitarou Futami; Kiyoshi Maeda; Tsuneo Iiai; Michio Itabashi; Kazuo Hase; Satoshi Motoya; Atsuo Kitano; Tsunekazu Mizushima; Kotaro Maeda; Minako Kobayashi; Yasuhiko Mohri; Masato Kusunoki
Journal:  Surg Today       Date:  2013-12-12       Impact factor: 2.549

3.  Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case.

Authors:  Haruki Sada; Manabu Shimomura; Takao Hinoi; Hiroyuki Egi; Koji Kawaguchi; Takuya Yano; Hiroaki Niitsu; Yasufumi Saitou; Hiroyuki Sawada; Masashi Miguchi; Tomohiro Adachi; Hideki Ohdan
Journal:  World J Surg Oncol       Date:  2015-03-26       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.